Stockreport

Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis

Telesis Bio, Inc.  (TBIO) 
PDF SAN DIEGO--(BUSINESS WIRE)--Telesis Bio, a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site au [Read more]